本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

4.13
-0.1600-3.73%
盘后4.210.0800+1.94%18:00 EDT
成交量:70.96万
成交额:295.57万
市值:4.63亿
市盈率:-2.62
高:4.31
开:4.28
低:4.11
收:4.29
52周最高:4.74
52周最低:1.05
股本:1.12亿
流通股本:9,224.08万
量比:0.59
换手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-1.5758
每股收益(LYR):-1.6246
净资产收益率:-705.53%
总资产收益率:-22.99%
市净率:-2.32
市盈率(LYR):-2.54

数据加载中...

2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/27

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/24

招股说明书

F-1 - Registration statement for certain foreign private issuers
2019/10/03

SEC问询函

CORRESP [Cover] - Correspondence
2019/09/30

SEC问询函

CORRESP [Cover] - Correspondence
2019/09/30

SEC问询函

CORRESP [Cover] - Correspondence
2019/09/23

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2019/09/09

SEC问询函

CORRESP [Cover] - Correspondence